Literature DB >> 15729159

Time to treatment for women with chlamydial or gonococcal infections: a comparative evaluation of sexually transmitted disease clinics in 3 US cities.

David Wong1, Stuart M Berman, Bruce W Furness, Robert A Gunn, Melanie Taylor, Thomas A Peterman.   

Abstract

BACKGROUND: Many women with positive screening tests for chlamydia or gonorrhea are not promptly treated and are at risk for complications and further disease transmission. Improved methods for notifying infected patients might increase timely treatment in this population. GOAL: Describe notification procedures at STD clinics in Washington, DC; Los Angeles; and San Diego and compare timeliness of treatment during 2000 to 2002. STUDY: Interviews were conducted to determine methods for notifying infected patients. Data were abstracted from 327 medical records of women with chlamydia or gonorrhea who had not been treated presumptively. The interval between specimen collection and treatment ("time to treatment") was calculated.
RESULTS: Each clinic had different procedures for notifying untreated infected women. Among those treated, the median time to treatment was 18 days in Washington, DC, and 8 days in Los Angeles. In San Diego, the median time to treatment was initially 14 days, which improved to 7 days after patient-notification procedures were changed.
CONCLUSION: Simple changes in patient notification procedures can decrease time to treatment at STD clinics. STD programs should evaluate time to treatment and institute methods for efficient patient follow-up.

Entities:  

Mesh:

Year:  2005        PMID: 15729159      PMCID: PMC6784324          DOI: 10.1097/01.olq.0000154494.95138.70

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  13 in total

1.  The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for Chlamydia trachomatis.

Authors:  T L Gift; M S Pate; E W Hook; W J Kassler
Journal:  Sex Transm Dis       Date:  1999-04       Impact factor: 2.830

2.  Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy.

Authors:  J M Marrazzo; C L Celum; S D Hillis; D Fine; S DeLisle; H H Handsfield
Journal:  Sex Transm Dis       Date:  1997-03       Impact factor: 2.830

Review 3.  Genital chlamydial infections: epidemiology and reproductive sequelae.

Authors:  W Cates; J N Wasserheit
Journal:  Am J Obstet Gynecol       Date:  1991-06       Impact factor: 8.661

4.  Serologic evidence for the role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy.

Authors:  A Miettinen; P K Heinonen; K Teisala; K Hakkarainen; R Punnonen
Journal:  Sex Transm Dis       Date:  1990 Jan-Mar       Impact factor: 2.830

5.  Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections--2002.

Authors:  Robert E Johnson; Wilbert J Newhall; John R Papp; Joan S Knapp; Carolyn M Black; Thomas L Gift; Richard Steece; Lauri E Markowitz; Owen J Devine; Cathleen M Walsh; Susan Wang; Dorothy C Gunter; Kathleen L Irwin; Susan DeLisle; Stuart M Berman
Journal:  MMWR Recomm Rep       Date:  2002-10-18

6.  Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center.

Authors:  L H Bachmann; C M Richey; K Waites; J R Schwebke; E W Hook
Journal:  Sex Transm Dis       Date:  1999-10       Impact factor: 2.830

7.  Results of a screening program for Chlamydia trachomatis infection in men attending a sexually transmitted diseases clinic.

Authors:  M A Urban; P Coury-Doniger; R C Reichman
Journal:  Sex Transm Dis       Date:  1997-11       Impact factor: 2.830

8.  Field-delivered therapy increases treatment for chlamydia and gonorrhea.

Authors:  Katherine C Steiner; Veronica Davila; Charlotte K Kent; Janice K Chaw; Lyn Fischer; Jeffrey D Klausner
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

9.  Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard.

Authors:  Carolyn M Black; Jeanne Marrazzo; Robert E Johnson; Edward W Hook; Robert B Jones; Timothy A Green; Julius Schachter; Walter E Stamm; Gail Bolan; Michael E St Louis; David H Martin
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

10.  Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening.

Authors:  E W Hook; C Spitters; C A Reichart; T M Neumann; T C Quinn
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

View more
  10 in total

1.  Missed and delayed syphilis treatment and partner elicitation: a comparison between STD clinic and non-STD clinic patients.

Authors:  Sanny Y Chen; Michelle Johnson; Rebecca Sunenshine; Bob England; Ken Komatsu; Melanie Taylor
Journal:  Sex Transm Dis       Date:  2009-07       Impact factor: 2.830

2.  Sexually transmitted diseases among American Indians in Arizona: an important public health disparity.

Authors:  Michelle Winscott; Melanie Taylor; Kerry Kenney
Journal:  Public Health Rep       Date:  2010 Jul-Aug       Impact factor: 2.792

3.  Point-of-care testing for sexually transmitted infections increases awareness and short-term abstinence in adolescent women.

Authors:  Jennifer L Reed; Lauren Simendinger; Sarah Griffeth; Hye Grace Kim; Jill S Huppert
Journal:  J Adolesc Health       Date:  2009-10-12       Impact factor: 5.012

4.  Improving notification of sexually transmitted infections: a quality improvement project and planned experiment.

Authors:  Jill S Huppert; Jennifer L Reed; Jennifer Knopf Munafo; Rachel Ekstrand; Gordon Gillespie; Carolyn Holland; Maria T Britto
Journal:  Pediatrics       Date:  2012-07-02       Impact factor: 7.124

5.  Chlamydia and gonorrhea diagnosis, treatment, personnel cost savings, and service delivery improvements after the implementation of express sexually transmitted disease testing in Maricopa County, Arizona.

Authors:  Sana Rukh; Renuka Khurana; Tom Mickey; Larissa Anderson; Corinne Velasquez; Melanie Taylor
Journal:  Sex Transm Dis       Date:  2014-01       Impact factor: 2.830

6.  Improving sexually transmitted infection results notification via mobile phone technology.

Authors:  Jennifer L Reed; Jill S Huppert; Regina G Taylor; Gordon L Gillespie; Terri L Byczkowski; Jessica A Kahn; Evaline A Alessandrini
Journal:  J Adolesc Health       Date:  2014-06-21       Impact factor: 5.012

7.  Care-Seeking Behavior After Notification Among Young Women With Recurrent Sexually Transmitted Infections After Pelvic Inflammatory Disease.

Authors:  Arlene M Butz; Charlotte Gaydos; Shang-En Chung; Betty H Johnson; Steven Huettner; Maria Trent
Journal:  Clin Pediatr (Phila)       Date:  2016-08-08       Impact factor: 1.168

8.  Interval to treatment of sexually transmitted infections in adolescent females.

Authors:  Amina I Malik; Jill S Huppert
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-10       Impact factor: 1.814

9.  The Potential Population-Level Impact of Different Gonorrhea Screening Strategies in Baltimore and San Francisco: An Exploratory Mathematical Modeling Analysis.

Authors:  Minttu M Rönn; Christian Testa; Ashleigh R Tuite; Harrell W Chesson; Thomas L Gift; Christina Schumacher; Sarah L Williford; Lin Zhu; Meghan Bellerose; Rebecca Earnest; Yelena Malyuta; Katherine K Hsu; Joshua A Salomon; Nicolas A Menzies
Journal:  Sex Transm Dis       Date:  2020-03       Impact factor: 3.868

10.  Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis.

Authors:  Minttu M Rönn; Nicolas A Menzies; Thomas L Gift; Harrell W Chesson; Tom A Trikalinos; Meghan Bellerose; Yelena Malyuta; Andrés Berruti; Charlotte A Gaydos; Katherine K Hsu; Joshua A Salomon
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.